FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.5.206

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113883.3.1444.5.206
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.206/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206
Version20200902
Statusactive
Date2020-09-02T01:00:26-04:00
NameTrastuzumabAndBiosimilars
TitleTrastuzumab and Biosimilars
Realmus
Authorityhl7
Purpose(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
ValueSet
2.16.840.1.113883.3.1444.3.101Trastuzumab and Biosimilars

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.5.206",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-11-25"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2020-09-02"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.1444.5.206"
    }
  ],
  "version": "20200902",
  "name": "TrastuzumabAndBiosimilars",
  "title": "Trastuzumab and Biosimilars",
  "status": "active",
  "experimental": false,
  "date": "2020-09-02T01:00:26-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:b834593e-a294-48fa-837e-e31dd0fd9b1a",
    "timestamp": "2025-05-23T21:56:30-04:00",
    "total": 17,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1658084",
        "display": "ado-trastuzumab emtansine 100 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1658089",
        "display": "ado-trastuzumab emtansine 160 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1922509",
        "display": "trastuzumab 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2107053",
        "display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2119714",
        "display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2169359",
        "display": "trastuzumab-pkrb 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2174804",
        "display": "trastuzumab-anns 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2179753",
        "display": "trastuzumab-dkst 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2179760",
        "display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2257297",
        "display": "trastuzumab-anns 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2267576",
        "display": "fam-trastuzumab deruxtecan-nxki 100 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2280732",
        "display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2289227",
        "display": "trastuzumab-dttb 150 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2289234",
        "display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2382604",
        "display": "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2383305",
        "display": "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2472791",
        "display": "trastuzumab-qyyp 150 MG Injection"
      }
    ]
  }
}